Sökning: WFRF:(Sandström Anneli) > Is mass screening f...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06755naa a2200637 4500 | |
001 | oai:lup.lub.lu.se:e5582dc2-3c6a-44e5-b96e-bb342d6af3d9 | |
003 | SwePub | |
008 | 210426s2021 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:liu-175605 | |
009 | oai:DiVA.org:umu-182472 | |
024 | 7 | a https://lup.lub.lu.se/record/e5582dc2-3c6a-44e5-b96e-bb342d6af3d92 URI |
024 | 7 | a https://doi.org/10.1186/s12876-021-01737-12 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1756052 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1824722 URI |
040 | a (SwePub)lud (SwePub)liud (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Norström, Fredriku Umeå universitet,Umeå University,Umea Univ, Sweden,Institutionen för epidemiologi och global hälsa4 aut0 (Swepub:umu)frno0004 |
245 | 1 0 | a Is mass screening for coeliac disease a wise use of resources? A health economic evaluation |
264 | c 2021-04-09 | |
264 | 1 | b Springer Science and Business Media LLC,c 2021 |
500 | a Funding Agencies|Umea University; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Research Council for Environment, Agricultural Sciences and Spatial PlanningSwedish Research Council Formas; Swedish Council for Working Life and Social ResearchSwedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte); Vardal Foundation; Swedish Coeliac Associations research fund | |
520 | a Background: Living with undiagnosed symptomatic coeliac disease is connected with deteriorated health, and persons with coeliac disease often wait a long time for their diagnosis. A mass screening would lower the delay, but its cost-effectiveness is still unclear. Our aim was to determine the cost-effectiveness of a coeliac disease mass screening at 12 years of age, taking a life course perspective on future benefits and drawbacks. Methods: The cost-effectiveness was derived as cost per quality-adjusted life-year (QALY) using a Markov model. As a basis for our assumptions, we mainly used information from the Exploring the Iceberg of Celiacs in Sweden (ETICS) study, a school-based screening conducted in 2005/2006 and 2009/2010, where 13,279 12-year-old children participated and 240 were diagnosed with coeliac disease, and a study involving members of the Swedish Coeliac Association with 1031 adult participants. Results: The cost for coeliac disease screening was 40,105 Euro per gained QALY. Sensitivity analyses support screening based on high compliance to a gluten-free diet, rapid progression from symptom-free coeliac disease to coeliac disease with symptoms, long delay from celiac disease with symptoms to diagnosis, and a low QALY score for undiagnosed coeliac disease cases. Conclusions: A coeliac disease mass screening is cost-effective based on the commonly used threshold of 50,000 Euro per gained QALY. However, this is based on many assumptions, especially regarding the natural history of coeliac disease and the effects on long-term health for individuals with coeliac disease still eating gluten. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
653 | a Adolescent | |
653 | a Coeliac disease | |
653 | a Compliance | |
653 | a Cost-effectiveness | |
653 | a Long delay | |
653 | a QALY | |
653 | a Screening | |
653 | a Coeliac disease; Cost-effectiveness; Compliance; Long delay; Screening; Adolescent; QALY | |
700 | 1 | a Myléus, Anna,c MD PhDu Umeå universitet,Umeå University,Umea Univ, Sweden,Allmänmedicin4 aut0 (Swepub:umu)anamys98 |
700 | 1 | a Nordyke, Katrinau Umeå universitet,Umeå University,Umea Univ, Sweden,Institutionen för epidemiologi och global hälsa4 aut0 (Swepub:umu)kaanoe03 |
700 | 1 | a Carlsson, Annelieu Umeå universitet,Lund University,Lunds universitet,Pediatrisk autoimmunitet,Forskargrupper vid Lunds universitet,Pediatric Autoimmunity,Lund University Research Groups,Department of Pediatrics, Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden,Lund Univ, Sweden,Umea Univ, Sweden,Institutionen för epidemiologi och global hälsa4 aut0 (Swepub:umu)aniv0001 |
700 | 1 | a Högberg, Lottau Linköpings universitet,Linköping University,Vrinnevi Hospital,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, Barn- och ungdomskliniken i Norrköping,Department of Paediatrics, Norrköping Hospital, Linköping University, Norrköping, Sweden4 aut0 (Swepub:liu)lotho28 |
700 | 1 | a Sandström, Olofu Umeå universitet,Umeå University,Umea Univ, Sweden; Umea Univ, Sweden,Institutionen för epidemiologi och global hälsa,Pediatrik4 aut0 (Swepub:umu)olsa0022 |
700 | 1 | a Stenhammar, Larsu Linköpings universitet,Linköping University,Vrinnevi Hospital,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, Barn- och ungdomskliniken i Norrköping,Department of Paediatrics, Norrköping Hospital, Linköping University, Norrköping, Sweden4 aut0 (Swepub:liu)larst66 |
700 | 1 | a Ivarsson, Anneliu Umeå University4 aut |
700 | 1 | a Lindholm, Larsu Umeå universitet,Umeå University,Umea Univ, Sweden,Institutionen för epidemiologi och global hälsa4 aut0 (Swepub:umu)lali0001 |
710 | 2 | a Umeå Universityb Umea Univ, Sweden4 org |
773 | 0 | t BMC Gastroenterologyd : Springer Science and Business Media LLCg 21:1q 21:1x 1471-230X |
856 | 4 | u http://dx.doi.org/10.1186/s12876-021-01737-1x freey FULLTEXT |
856 | 4 | u https://bmcgastroenterol.biomedcentral.com/track/pdf/10.1186/s12876-021-01737-1 |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1553823/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://doi.org/10.1186/s12876-021-01737-1y Fulltext |
856 | 4 | u https://umu.diva-portal.org/smash/get/diva2:1548168/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://lup.lub.lu.se/record/e5582dc2-3c6a-44e5-b96e-bb342d6af3d9 |
856 | 4 8 | u https://doi.org/10.1186/s12876-021-01737-1 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-175605 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-182472 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy